[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Biopharmaceuticals Contract Manufacturing Market 2023 by Company, Regions, Type and Application, Forecast to 2029

February 2023 | 104 pages | ID: G6049391D2A8EN
GlobalInfoResearch

US$ 3,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
Contract manufacturing organization is a company that serve other companies in the biopharmaceutical industry on a contract basis to provide comprehensive services from drug development through drug manufacturing.

According to our (Global Info Research) latest study, the global Biopharmaceuticals Contract Manufacturing market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report is a detailed and comprehensive analysis for global Biopharmaceuticals Contract Manufacturing market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.

Key Features:

Global Biopharmaceuticals Contract Manufacturing market size and forecasts, in consumption value ($ Million), 2018-2029

Global Biopharmaceuticals Contract Manufacturing market size and forecasts by region and country, in consumption value ($ Million), 2018-2029

Global Biopharmaceuticals Contract Manufacturing market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029

Global Biopharmaceuticals Contract Manufacturing market shares of main players, in revenue ($ Million), 2018-2023

The Primary Objectives in This Report Are:

To determine the size of the total market opportunity of global and key countries

To assess the growth potential for Biopharmaceuticals Contract Manufacturing

To forecast future growth in each product and end-use market

To assess competitive factors affecting the marketplace

This report profiles key players in the global Biopharmaceuticals Contract Manufacturing market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Boehringer Ingelheim, Lonza Group AG, Inno Biologics Sdn Bhd, Rentschler Biopharma and JRS Pharma, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Market segmentation

Biopharmaceuticals Contract Manufacturing market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type
  • Biologics
  • Biosimilars
Market segment by Application
  • Process Development
  • Packaging
  • Others
Market segment by players, this report covers
  • Boehringer Ingelheim
  • Lonza Group AG
  • Inno Biologics Sdn Bhd
  • Rentschler Biopharma
  • JRS Pharma
  • AGC Biologics
  • ProBioGen
  • FUJIFILM Diosynth Biotechnologies
  • Toyobo Co., Ltd.
  • Samsung Biologics
  • Thermo Fisher Scientific
  • Binex Co., Ltd.
  • WuXi Biologics
  • AbbVie, Inc.
Market segment by regions, regional analysis covers
  • North America (United States, Canada, and Mexico)
  • Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
  • South America (Brazil, Argentina and Rest of South America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:

Chapter 1, to describe Biopharmaceuticals Contract Manufacturing product scope, market overview, market estimation caveats and base year.

Chapter 2, to profile the top players of Biopharmaceuticals Contract Manufacturing, with revenue, gross margin and global market share of Biopharmaceuticals Contract Manufacturing from 2018 to 2023.

Chapter 3, the Biopharmaceuticals Contract Manufacturing competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.

Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.

Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Biopharmaceuticals Contract Manufacturing market forecast, by regions, type and application, with consumption value, from 2024 to 2029.

Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War

Chapter 12, the key raw materials and key suppliers, and industry chain of Biopharmaceuticals Contract Manufacturing.

Chapter 13, to describe Biopharmaceuticals Contract Manufacturing research findings and conclusion.
1 MARKET OVERVIEW

1.1 Product Overview and Scope of Biopharmaceuticals Contract Manufacturing
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Biopharmaceuticals Contract Manufacturing by Type
  1.3.1 Overview: Global Biopharmaceuticals Contract Manufacturing Market Size by Type: 2018 Versus 2022 Versus 2029
  1.3.2 Global Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Type in 2022
  1.3.3 Biologics
  1.3.4 Biosimilars
1.4 Global Biopharmaceuticals Contract Manufacturing Market by Application
  1.4.1 Overview: Global Biopharmaceuticals Contract Manufacturing Market Size by Application: 2018 Versus 2022 Versus 2029
  1.4.2 Process Development
  1.4.3 Packaging
  1.4.4 Others
1.5 Global Biopharmaceuticals Contract Manufacturing Market Size & Forecast
1.6 Global Biopharmaceuticals Contract Manufacturing Market Size and Forecast by Region
  1.6.1 Global Biopharmaceuticals Contract Manufacturing Market Size by Region: 2018 VS 2022 VS 2029
  1.6.2 Global Biopharmaceuticals Contract Manufacturing Market Size by Region, (2018-2029)
  1.6.3 North America Biopharmaceuticals Contract Manufacturing Market Size and Prospect (2018-2029)
  1.6.4 Europe Biopharmaceuticals Contract Manufacturing Market Size and Prospect (2018-2029)
  1.6.5 Asia-Pacific Biopharmaceuticals Contract Manufacturing Market Size and Prospect (2018-2029)
  1.6.6 South America Biopharmaceuticals Contract Manufacturing Market Size and Prospect (2018-2029)
  1.6.7 Middle East and Africa Biopharmaceuticals Contract Manufacturing Market Size and Prospect (2018-2029)

2 COMPANY PROFILES

2.1 Boehringer Ingelheim
  2.1.1 Boehringer Ingelheim Details
  2.1.2 Boehringer Ingelheim Major Business
  2.1.3 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Product and Solutions
  2.1.4 Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.1.5 Boehringer Ingelheim Recent Developments and Future Plans
2.2 Lonza Group AG
  2.2.1 Lonza Group AG Details
  2.2.2 Lonza Group AG Major Business
  2.2.3 Lonza Group AG Biopharmaceuticals Contract Manufacturing Product and Solutions
  2.2.4 Lonza Group AG Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.2.5 Lonza Group AG Recent Developments and Future Plans
2.3 Inno Biologics Sdn Bhd
  2.3.1 Inno Biologics Sdn Bhd Details
  2.3.2 Inno Biologics Sdn Bhd Major Business
  2.3.3 Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Product and Solutions
  2.3.4 Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.3.5 Inno Biologics Sdn Bhd Recent Developments and Future Plans
2.4 Rentschler Biopharma
  2.4.1 Rentschler Biopharma Details
  2.4.2 Rentschler Biopharma Major Business
  2.4.3 Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Product and Solutions
  2.4.4 Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.4.5 Rentschler Biopharma Recent Developments and Future Plans
2.5 JRS Pharma
  2.5.1 JRS Pharma Details
  2.5.2 JRS Pharma Major Business
  2.5.3 JRS Pharma Biopharmaceuticals Contract Manufacturing Product and Solutions
  2.5.4 JRS Pharma Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.5.5 JRS Pharma Recent Developments and Future Plans
2.6 AGC Biologics
  2.6.1 AGC Biologics Details
  2.6.2 AGC Biologics Major Business
  2.6.3 AGC Biologics Biopharmaceuticals Contract Manufacturing Product and Solutions
  2.6.4 AGC Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.6.5 AGC Biologics Recent Developments and Future Plans
2.7 ProBioGen
  2.7.1 ProBioGen Details
  2.7.2 ProBioGen Major Business
  2.7.3 ProBioGen Biopharmaceuticals Contract Manufacturing Product and Solutions
  2.7.4 ProBioGen Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.7.5 ProBioGen Recent Developments and Future Plans
2.8 FUJIFILM Diosynth Biotechnologies
  2.8.1 FUJIFILM Diosynth Biotechnologies Details
  2.8.2 FUJIFILM Diosynth Biotechnologies Major Business
  2.8.3 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Product and Solutions
  2.8.4 FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.8.5 FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
2.9 Toyobo Co., Ltd.
  2.9.1 Toyobo Co., Ltd. Details
  2.9.2 Toyobo Co., Ltd. Major Business
  2.9.3 Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Product and Solutions
  2.9.4 Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.9.5 Toyobo Co., Ltd. Recent Developments and Future Plans
2.10 Samsung Biologics
  2.10.1 Samsung Biologics Details
  2.10.2 Samsung Biologics Major Business
  2.10.3 Samsung Biologics Biopharmaceuticals Contract Manufacturing Product and Solutions
  2.10.4 Samsung Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.10.5 Samsung Biologics Recent Developments and Future Plans
2.11 Thermo Fisher Scientific
  2.11.1 Thermo Fisher Scientific Details
  2.11.2 Thermo Fisher Scientific Major Business
  2.11.3 Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Product and Solutions
  2.11.4 Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.11.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.12 Binex Co., Ltd.
  2.12.1 Binex Co., Ltd. Details
  2.12.2 Binex Co., Ltd. Major Business
  2.12.3 Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Product and Solutions
  2.12.4 Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.12.5 Binex Co., Ltd. Recent Developments and Future Plans
2.13 WuXi Biologics
  2.13.1 WuXi Biologics Details
  2.13.2 WuXi Biologics Major Business
  2.13.3 WuXi Biologics Biopharmaceuticals Contract Manufacturing Product and Solutions
  2.13.4 WuXi Biologics Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.13.5 WuXi Biologics Recent Developments and Future Plans
2.14 AbbVie, Inc.
  2.14.1 AbbVie, Inc. Details
  2.14.2 AbbVie, Inc. Major Business
  2.14.3 AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Product and Solutions
  2.14.4 AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Revenue, Gross Margin and Market Share (2018-2023)
  2.14.5 AbbVie, Inc. Recent Developments and Future Plans

3 MARKET COMPETITION, BY PLAYERS

3.1 Global Biopharmaceuticals Contract Manufacturing Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
  3.2.1 Market Share of Biopharmaceuticals Contract Manufacturing by Company Revenue
  3.2.2 Top 3 Biopharmaceuticals Contract Manufacturing Players Market Share in 2022
  3.2.3 Top 6 Biopharmaceuticals Contract Manufacturing Players Market Share in 2022
3.3 Biopharmaceuticals Contract Manufacturing Market: Overall Company Footprint Analysis
  3.3.1 Biopharmaceuticals Contract Manufacturing Market: Region Footprint
  3.3.2 Biopharmaceuticals Contract Manufacturing Market: Company Product Type Footprint
  3.3.3 Biopharmaceuticals Contract Manufacturing Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations

4 MARKET SIZE SEGMENT BY TYPE

4.1 Global Biopharmaceuticals Contract Manufacturing Consumption Value and Market Share by Type (2018-2023)
4.2 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Type (2024-2029)

5 MARKET SIZE SEGMENT BY APPLICATION

5.1 Global Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Application (2018-2023)
5.2 Global Biopharmaceuticals Contract Manufacturing Market Forecast by Application (2024-2029)

6 NORTH AMERICA

6.1 North America Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2018-2029)
6.2 North America Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2018-2029)
6.3 North America Biopharmaceuticals Contract Manufacturing Market Size by Country
  6.3.1 North America Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2018-2029)
  6.3.2 United States Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
  6.3.3 Canada Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
  6.3.4 Mexico Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)

7 EUROPE

7.1 Europe Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2018-2029)
7.2 Europe Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2018-2029)
7.3 Europe Biopharmaceuticals Contract Manufacturing Market Size by Country
  7.3.1 Europe Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2018-2029)
  7.3.2 Germany Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
  7.3.3 France Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
  7.3.4 United Kingdom Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
  7.3.5 Russia Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
  7.3.6 Italy Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)

8 ASIA-PACIFIC

8.1 Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Biopharmaceuticals Contract Manufacturing Market Size by Region
  8.3.1 Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value by Region (2018-2029)
  8.3.2 China Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
  8.3.3 Japan Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
  8.3.4 South Korea Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
  8.3.5 India Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
  8.3.6 Southeast Asia Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
  8.3.7 Australia Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)

9 SOUTH AMERICA

9.1 South America Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2018-2029)
9.2 South America Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2018-2029)
9.3 South America Biopharmaceuticals Contract Manufacturing Market Size by Country
  9.3.1 South America Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2018-2029)
  9.3.2 Brazil Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
  9.3.3 Argentina Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)

10 MIDDLE EAST & AFRICA

10.1 Middle East & Africa Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Biopharmaceuticals Contract Manufacturing Market Size by Country
  10.3.1 Middle East & Africa Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2018-2029)
  10.3.2 Turkey Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
  10.3.3 Saudi Arabia Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)
  10.3.4 UAE Biopharmaceuticals Contract Manufacturing Market Size and Forecast (2018-2029)

11 MARKET DYNAMICS

11.1 Biopharmaceuticals Contract Manufacturing Market Drivers
11.2 Biopharmaceuticals Contract Manufacturing Market Restraints
11.3 Biopharmaceuticals Contract Manufacturing Trends Analysis
11.4 Porters Five Forces Analysis
  11.4.1 Threat of New Entrants
  11.4.2 Bargaining Power of Suppliers
  11.4.3 Bargaining Power of Buyers
  11.4.4 Threat of Substitutes
  11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
  11.5.1 Influence of COVID-19
  11.5.2 Influence of Russia-Ukraine War

12 INDUSTRY CHAIN ANALYSIS

12.1 Biopharmaceuticals Contract Manufacturing Industry Chain
12.2 Biopharmaceuticals Contract Manufacturing Upstream Analysis
12.3 Biopharmaceuticals Contract Manufacturing Midstream Analysis
12.4 Biopharmaceuticals Contract Manufacturing Downstream Analysis

13 RESEARCH FINDINGS AND CONCLUSION

14 APPENDIX

14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

LIST OF TABLES

Table 1. Global Biopharmaceuticals Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Biopharmaceuticals Contract Manufacturing Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Biopharmaceuticals Contract Manufacturing Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Biopharmaceuticals Contract Manufacturing Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Boehringer Ingelheim Company Information, Head Office, and Major Competitors
Table 6. Boehringer Ingelheim Major Business
Table 7. Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Product and Solutions
Table 8. Boehringer Ingelheim Biopharmaceuticals Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Boehringer Ingelheim Recent Developments and Future Plans
Table 10. Lonza Group AG Company Information, Head Office, and Major Competitors
Table 11. Lonza Group AG Major Business
Table 12. Lonza Group AG Biopharmaceuticals Contract Manufacturing Product and Solutions
Table 13. Lonza Group AG Biopharmaceuticals Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Lonza Group AG Recent Developments and Future Plans
Table 15. Inno Biologics Sdn Bhd Company Information, Head Office, and Major Competitors
Table 16. Inno Biologics Sdn Bhd Major Business
Table 17. Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Product and Solutions
Table 18. Inno Biologics Sdn Bhd Biopharmaceuticals Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Inno Biologics Sdn Bhd Recent Developments and Future Plans
Table 20. Rentschler Biopharma Company Information, Head Office, and Major Competitors
Table 21. Rentschler Biopharma Major Business
Table 22. Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Product and Solutions
Table 23. Rentschler Biopharma Biopharmaceuticals Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Rentschler Biopharma Recent Developments and Future Plans
Table 25. JRS Pharma Company Information, Head Office, and Major Competitors
Table 26. JRS Pharma Major Business
Table 27. JRS Pharma Biopharmaceuticals Contract Manufacturing Product and Solutions
Table 28. JRS Pharma Biopharmaceuticals Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. JRS Pharma Recent Developments and Future Plans
Table 30. AGC Biologics Company Information, Head Office, and Major Competitors
Table 31. AGC Biologics Major Business
Table 32. AGC Biologics Biopharmaceuticals Contract Manufacturing Product and Solutions
Table 33. AGC Biologics Biopharmaceuticals Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. AGC Biologics Recent Developments and Future Plans
Table 35. ProBioGen Company Information, Head Office, and Major Competitors
Table 36. ProBioGen Major Business
Table 37. ProBioGen Biopharmaceuticals Contract Manufacturing Product and Solutions
Table 38. ProBioGen Biopharmaceuticals Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. ProBioGen Recent Developments and Future Plans
Table 40. FUJIFILM Diosynth Biotechnologies Company Information, Head Office, and Major Competitors
Table 41. FUJIFILM Diosynth Biotechnologies Major Business
Table 42. FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Product and Solutions
Table 43. FUJIFILM Diosynth Biotechnologies Biopharmaceuticals Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. FUJIFILM Diosynth Biotechnologies Recent Developments and Future Plans
Table 45. Toyobo Co., Ltd. Company Information, Head Office, and Major Competitors
Table 46. Toyobo Co., Ltd. Major Business
Table 47. Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Product and Solutions
Table 48. Toyobo Co., Ltd. Biopharmaceuticals Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Toyobo Co., Ltd. Recent Developments and Future Plans
Table 50. Samsung Biologics Company Information, Head Office, and Major Competitors
Table 51. Samsung Biologics Major Business
Table 52. Samsung Biologics Biopharmaceuticals Contract Manufacturing Product and Solutions
Table 53. Samsung Biologics Biopharmaceuticals Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. Samsung Biologics Recent Developments and Future Plans
Table 55. Thermo Fisher Scientific Company Information, Head Office, and Major Competitors
Table 56. Thermo Fisher Scientific Major Business
Table 57. Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Product and Solutions
Table 58. Thermo Fisher Scientific Biopharmaceuticals Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 59. Thermo Fisher Scientific Recent Developments and Future Plans
Table 60. Binex Co., Ltd. Company Information, Head Office, and Major Competitors
Table 61. Binex Co., Ltd. Major Business
Table 62. Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Product and Solutions
Table 63. Binex Co., Ltd. Biopharmaceuticals Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 64. Binex Co., Ltd. Recent Developments and Future Plans
Table 65. WuXi Biologics Company Information, Head Office, and Major Competitors
Table 66. WuXi Biologics Major Business
Table 67. WuXi Biologics Biopharmaceuticals Contract Manufacturing Product and Solutions
Table 68. WuXi Biologics Biopharmaceuticals Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 69. WuXi Biologics Recent Developments and Future Plans
Table 70. AbbVie, Inc. Company Information, Head Office, and Major Competitors
Table 71. AbbVie, Inc. Major Business
Table 72. AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Product and Solutions
Table 73. AbbVie, Inc. Biopharmaceuticals Contract Manufacturing Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 74. AbbVie, Inc. Recent Developments and Future Plans
Table 75. Global Biopharmaceuticals Contract Manufacturing Revenue (USD Million) by Players (2018-2023)
Table 76. Global Biopharmaceuticals Contract Manufacturing Revenue Share by Players (2018-2023)
Table 77. Breakdown of Biopharmaceuticals Contract Manufacturing by Company Type (Tier 1, Tier 2, and Tier 3)
Table 78. Market Position of Players in Biopharmaceuticals Contract Manufacturing, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 79. Head Office of Key Biopharmaceuticals Contract Manufacturing Players
Table 80. Biopharmaceuticals Contract Manufacturing Market: Company Product Type Footprint
Table 81. Biopharmaceuticals Contract Manufacturing Market: Company Product Application Footprint
Table 82. Biopharmaceuticals Contract Manufacturing New Market Entrants and Barriers to Market Entry
Table 83. Biopharmaceuticals Contract Manufacturing Mergers, Acquisition, Agreements, and Collaborations
Table 84. Global Biopharmaceuticals Contract Manufacturing Consumption Value (USD Million) by Type (2018-2023)
Table 85. Global Biopharmaceuticals Contract Manufacturing Consumption Value Share by Type (2018-2023)
Table 86. Global Biopharmaceuticals Contract Manufacturing Consumption Value Forecast by Type (2024-2029)
Table 87. Global Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2018-2023)
Table 88. Global Biopharmaceuticals Contract Manufacturing Consumption Value Forecast by Application (2024-2029)
Table 89. North America Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 90. North America Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 91. North America Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 92. North America Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 93. North America Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 94. North America Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 95. Europe Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 96. Europe Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 97. Europe Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 98. Europe Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 99. Europe Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 100. Europe Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 101. Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 102. Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 103. Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 104. Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 105. Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value by Region (2018-2023) & (USD Million)
Table 106. Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value by Region (2024-2029) & (USD Million)
Table 107. South America Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 108. South America Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 109. South America Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 110. South America Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 111. South America Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 112. South America Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 113. Middle East & Africa Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2018-2023) & (USD Million)
Table 114. Middle East & Africa Biopharmaceuticals Contract Manufacturing Consumption Value by Type (2024-2029) & (USD Million)
Table 115. Middle East & Africa Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2018-2023) & (USD Million)
Table 116. Middle East & Africa Biopharmaceuticals Contract Manufacturing Consumption Value by Application (2024-2029) & (USD Million)
Table 117. Middle East & Africa Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2018-2023) & (USD Million)
Table 118. Middle East & Africa Biopharmaceuticals Contract Manufacturing Consumption Value by Country (2024-2029) & (USD Million)
Table 119. Biopharmaceuticals Contract Manufacturing Raw Material
Table 120. Key Suppliers of Biopharmaceuticals Contract Manufacturing Raw Materials

LIST OF FIGURES

Figure 1. Biopharmaceuticals Contract Manufacturing Picture
Figure 2. Global Biopharmaceuticals Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Type in 2022
Figure 4. Biologics
Figure 5. Biosimilars
Figure 6. Global Biopharmaceuticals Contract Manufacturing Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 7. Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Application in 2022
Figure 8. Process Development Picture
Figure 9. Packaging Picture
Figure 10. Others Picture
Figure 11. Global Biopharmaceuticals Contract Manufacturing Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Biopharmaceuticals Contract Manufacturing Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Market Biopharmaceuticals Contract Manufacturing Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 14. Global Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Region (2018-2029)
Figure 15. Global Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Region in 2022
Figure 16. North America Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 17. Europe Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 18. Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 19. South America Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 20. Middle East and Africa Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 21. Global Biopharmaceuticals Contract Manufacturing Revenue Share by Players in 2022
Figure 22. Biopharmaceuticals Contract Manufacturing Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 23. Global Top 3 Players Biopharmaceuticals Contract Manufacturing Market Share in 2022
Figure 24. Global Top 6 Players Biopharmaceuticals Contract Manufacturing Market Share in 2022
Figure 25. Global Biopharmaceuticals Contract Manufacturing Consumption Value Share by Type (2018-2023)
Figure 26. Global Biopharmaceuticals Contract Manufacturing Market Share Forecast by Type (2024-2029)
Figure 27. Global Biopharmaceuticals Contract Manufacturing Consumption Value Share by Application (2018-2023)
Figure 28. Global Biopharmaceuticals Contract Manufacturing Market Share Forecast by Application (2024-2029)
Figure 29. North America Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 30. North America Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 31. North America Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 32. United States Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 33. Canada Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 34. Mexico Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 35. Europe Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 36. Europe Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 37. Europe Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 38. Germany Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 39. France Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 40. United Kingdom Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 41. Russia Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 42. Italy Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 43. Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 44. Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 45. Asia-Pacific Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Region (2018-2029)
Figure 46. China Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 47. Japan Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 48. South Korea Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 49. India Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 50. Southeast Asia Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 51. Australia Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 52. South America Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 53. South America Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 54. South America Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 55. Brazil Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 56. Argentina Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 57. Middle East and Africa Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Type (2018-2029)
Figure 58. Middle East and Africa Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Application (2018-2029)
Figure 59. Middle East and Africa Biopharmaceuticals Contract Manufacturing Consumption Value Market Share by Country (2018-2029)
Figure 60. Turkey Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 61. Saudi Arabia Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 62. UAE Biopharmaceuticals Contract Manufacturing Consumption Value (2018-2029) & (USD Million)
Figure 63. Biopharmaceuticals Contract Manufacturing Market Drivers
Figure 64. Biopharmaceuticals Contract Manufacturing Market Restraints
Figure 65. Biopharmaceuticals Contract Manufacturing Market Trends
Figure 66. Porters Five Forces Analysis
Figure 67. Manufacturing Cost Structure Analysis of Biopharmaceuticals Contract Manufacturing in 2022
Figure 68. Manufacturing Process Analysis of Biopharmaceuticals Contract Manufacturing
Figure 69. Biopharmaceuticals Contract Manufacturing Industrial Chain
Figure 70. Methodology
Figure 71. Research Process and Data Source


More Publications